Do toxicity patterns vary between programmed death-1 and programmed death ligand-1 inhibitors?
J Thorac Dis
.
2018 Nov;10(Suppl 33):S4069-S4072.
doi: 10.21037/jtd.2018.09.102.
Authors
Dwight H Owen
1
,
Gregory A Otterson
1
Affiliation
1
Division of Medical Oncology, Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
PMID:
30631557
PMCID:
PMC6297519
DOI:
10.21037/jtd.2018.09.102
No abstract available
Publication types
Editorial
Comment